{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:28:56Z","timestamp":1780324136222,"version":"3.54.1"},"reference-count":50,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Melatonin (MLT) is involved in many functions of the human body, mainly in sleeping-related disorders. It also has anti-oxidant potential and has been proven very effective in the treatment of seasonal affective disorders (SAD), which afflict some people during short winter days. Melatonin has been implicated in a range of other conditions, including Parkinson\u2019s disease, Alzheimer\u2019s and other neurological conditions, and in certain cancers. Its poor solubility in water leads to an insufficient absorption that led scientists to investigate MLT inclusion in cyclodextrins (CDs), as inclusion of drugs in CDs is a way of increasing the solubility of many lipophilic moieties with poor water solubility. The aim of this review is to gather all the key findings on MLT\/CD complexes. The literature appraisal concluded that MLT inclusion leads to a 1:1 complex with the majority of CDs and increases the solubility of the hormone. The interactions of MLT with CDs can be studied by a variety of techniques, such as NMR, FT-IR, XRD and DCS. More importantly, the in vivo experiments showed an increase in the uptake of MLT when included in a CD.<\/jats:p>","DOI":"10.3390\/molecules27020445","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T22:03:13Z","timestamp":1641852193000},"page":"445","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Melatonin\/Cyclodextrin Inclusion Complexes: A Review"],"prefix":"10.3390","volume":"27","author":[{"given":"Aikaterini","family":"Sakellaropoulou","sequence":"first","affiliation":[{"name":"Section of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 15784 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-408X","authenticated-orcid":false,"given":"Angeliki","family":"Siamidi","sequence":"additional","affiliation":[{"name":"Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2927-705X","authenticated-orcid":false,"given":"Marilena","family":"Vlachou","sequence":"additional","affiliation":[{"name":"Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15784 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"119775","DOI":"10.1016\/j.ijpharm.2020.119775","article-title":"Inclusion complex of tricyclic drugs and \u03b2-cyclodextrin: Inherent chirality and dynamic behavior","volume":"588","author":"Ferro","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/10717544.2014.938839","article-title":"Exploring versatile applications of cyclodextrins: An overview","volume":"23","author":"Sharma","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Braga, S.S. (2019). Cyclodextrins: Emerging Medicines of the New Millennium. Biomolecules, 9.","DOI":"10.3390\/biom9120801"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3797\/scipharm.0808-05","article-title":"Cyclodextrins as drug carrier molecule: A review","volume":"76","author":"Rasheed","year":"2008","journal-title":"Sci. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","article-title":"The utility of cyclodextrins for enhancing oral bioavailability","volume":"123","author":"Carrier","year":"2007","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: Structure, physiochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1021\/ja01531a060","article-title":"Structure of melatonin","volume":"81","author":"Lerner","year":"1959","journal-title":"J. Am. Chem. Soc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biocel.2005.08.020","article-title":"Melatonin","volume":"38","author":"Hardeland","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1073\/pnas.86.3.1098","article-title":"Retinal melatonin is metabolized within the eye of Xenopus laevis","volume":"86","author":"Cahill","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification and Pharmacology of G Protein-Coupled Melatonin Receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.14116","article-title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","volume":"175","author":"Zisapel","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smrv.2004.05.002","article-title":"Melatonin as a chronobiotic","volume":"9","author":"Arendt","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.sleep.2007.10.007","article-title":"Melatonin receptors: Role on sleep and circadian rhythm regulation","volume":"8","author":"Dubocovich","year":"2007","journal-title":"Sleep Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-079X.2007.00518.x","article-title":"Cardiovasular diseases: Protective effects of melatonin","volume":"44","author":"Tengattini","year":"2007","journal-title":"J. Pineal Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12525","DOI":"10.1111\/jpi.12525","article-title":"Melatonin and inflammation-story of a double-edged blade","volume":"65","author":"Hardeland","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1534735408322846","article-title":"Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms","volume":"7","author":"Srinvasan","year":"2008","journal-title":"Integr. Cancer Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.3390\/ijms140611742","article-title":"Modulation by melatonin of the Pathogenesis of Inflammatory Autoimmune Diseases","volume":"14","author":"Lin","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.3390\/ijms140714575","article-title":"Melatonin in Alzheimer\u2019s Disease","volume":"14","author":"Lin","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1385\/ENDO:27:2:169","article-title":"Melatonin and Parkinson\u2019s Disease","volume":"27","author":"Mayo","year":"2005","journal-title":"Endocrine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5664\/jcsm.8896","article-title":"Hit or miss: The use of melatonin supplements","volume":"16","author":"Goldstein","year":"2020","journal-title":"J. Clin. Sleep Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/156720106777731073","article-title":"Pineal Hormone Melatonin: Solubilization Studies in Model Aqueous Gastrointestinal Environments","volume":"3","author":"Vlachou","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpha.2017.04.001","article-title":"Formulation, stability testing and analytical characterization of melatonin-based preparation for clinical trial","volume":"7","author":"Filali","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000123997","article-title":"Bioavailability of Oral Melatonin in Humans","volume":"39","author":"Waldhauser","year":"1984","journal-title":"Neuroendocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1590\/S0103-50532006000300020","article-title":"Development of Nanocapsule Suspensions and Nanocapsule Spray-Dried Powders Containing Melatonin","volume":"17","author":"Schaffazick","year":"2006","journal-title":"J. Braz. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijpharm.2015.11.028","article-title":"Melatonin\/HP\u03b2CD: Microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS","volume":"496","author":"Topal","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jddst.2019.05.027","article-title":"Dual-functional melatonin releasing device loaded with PLGA microparticles and cyclodextrin inclusion complex for osteosarcoma therapy","volume":"52","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111554","DOI":"10.1016\/j.msec.2020.111554","article-title":"Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells","volume":"119","author":"Niu","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_30","first-page":"664","article-title":"Inclusion complexes of melatonin and randomly methylated \u03b2-cyclodextrin: Spectroscopic study","volume":"21","author":"Grygorova","year":"2019","journal-title":"Funct. Mater."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10847-013-0290-5","article-title":"Inclusion complexes of melatonin with modified cyclodextrins","volume":"78","author":"Maeda","year":"2014","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3998\/ark.5550190.0006.e14","article-title":"Inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin in solid phase","volume":"2005","author":"Bongiorno","year":"2005","journal-title":"Arkivok"},{"key":"ref_33","first-page":"642","article-title":"Modified release bi-layered tablet of melatonin using \u03b2-cyclodextrin","volume":"58","author":"Kumar","year":"2003","journal-title":"Pharmazie"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vlachou, M., Papamichael, M., Siamidi, A., Fragouli, I., Afroudakis, P.A., Kompogennitaki, R., and Dotsikas, Y. (2017). Comparative In Vitro controlled release studies on the chronobiotic hormone melatonin from cyclodextrins-containing matrices and cyclodextrin:melatonin complexes. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081641"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.carbpol.2016.01.024","article-title":"Preparation of functionalized cotton fabrics by means of melatonin loaded \u03b2-cyclodextrin nanosponges","volume":"142","author":"Mihailiasa","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.biomaterials.2005.04.011","article-title":"Synthesis, properties and controlled release behaviors of hydrogel networks using cyclodextrin as pendant groups","volume":"26","author":"Liu","year":"2005","journal-title":"Biomaterials"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10717540802006922","article-title":"Effect of cyclodextrins on the complexation and nasal permeation of melatonin","volume":"15","author":"Babu","year":"2008","journal-title":"Drug Deliv."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijpharm.2017.07.016","article-title":"Intracorneal melatonin delivery using 2-hydroxypropyl-\u03b2-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2","volume":"529","author":"Ahn","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2018.05.063","article-title":"Enhanced cellular uptake and osteogenic differentiation efficiency of melatonin by inclusion complexation with 2-hydroxypropyl \u03b2-cyclodextrin","volume":"547","author":"Terauchi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_40","first-page":"25","article-title":"An intravenous injection of melatonin: Formulation, stability, pharmacokinetics and pharmacodynamics","volume":"1","author":"Johns","year":"2012","journal-title":"JAASP"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2018.06.046","article-title":"Evaluation of novel formulations of D-\u03b2-hydroxybutyrate and melatonin in a rat model of hemorrhagic shock","volume":"548","author":"Wolf","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02975365","article-title":"Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"21","author":"Lee","year":"1998","journal-title":"Arch. Pharm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3109\/03639049509063026","article-title":"Development of a transdermal delivery device for melatonin in vitro study","volume":"21","author":"Konsil","year":"1995","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0008-6215(02)00049-6","article-title":"Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin","volume":"337","author":"Bongiorno","year":"2002","journal-title":"Carbohydr. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.saa.2017.09.042","article-title":"New insights on the spectrophotometric determination of melatonin pKa values and melatonin-\u03b2CD inclusion complex formation constant","volume":"190","year":"2018","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF02975212","article-title":"Solubility and stability of melatonin in propylene glycol and 2-hydroxypropyl-\u03b2-cyclodextrin vehicles","volume":"20","author":"Lee","year":"1997","journal-title":"Arch. Pharm. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jphotochem.2008.03.007","article-title":"Comparative effect of cyclodextrin nanocavities versus organic solvents on the fluorescence of carbamate and indole compounds","volume":"198","author":"Pacioni","year":"2008","journal-title":"J. Photochem. Photobiol. A"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Szente, L., Singhal, A., Domokos, A., and Song, B. (2018). Cyclodextrins: Assessing the Impact of Cavity Size, Occupancy, and Substitutions on Cytotoxicity and Cholesterol Homeostasis. Molecules, 23.","DOI":"10.3390\/molecules23051228"},{"key":"ref_49","first-page":"529","article-title":"Nanosponges-Novel emerging drug delivery system: A review","volume":"6","author":"Shivani","year":"2015","journal-title":"IJPSR"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ferrero, R., Pantaleone, S., Delle Piane, M., Caldera, F., Corno, M., Trotta, F., and Brunella, V. (2021). On the interactions of melatonin\/\u03b2-cyclodextrin inclusion complex: A novel approach combining efficient semiempirical extended tight-binding (xTB) results with ab initio methods. Molecules, 26.","DOI":"10.3390\/molecules26195881"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/2\/445\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:14:47Z","timestamp":1760364887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/2\/445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["molecules27020445"],"URL":"https:\/\/doi.org\/10.3390\/molecules27020445","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}